Drug Master Files for: TAVABOROLE
✉ Email this page to a colleague
TAVABOROLE Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
31283 | A | II | 1/31/2017 | GLENMARK PHARMACEUTICALS LTD | TAVABOROLE |
31431 | A | II | 3/2/2017 | BIOPHORE INDIA PHARMACEUTICALS PVT LTD | TAVABOROLE |
32083 | A | II | 3/26/2018 | TARO PHARMACEUTICAL INDUSTRIES LTD | TAVABOROLE |
32154 | A | II | 10/30/2017 | MSN LIFE SCIENCES PRIVATE LTD | TAVABOROLE |
32315 | A | II | 12/31/2017 | WAVELENGTH ENTERPRISES LTD | TAVABOROLE |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information